Wimmer Associates 1’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wimmer Associates 1's LLY Position: Q2 2026 in Review
Wimmer Associates 1 increased its Eli Lilly (LLY) stake by 3.1% in Q2 2026, buying an estimated $76.6K and bringing the position to 2,470 shares worth $2.96M. The position accounts for 1.34% of the portfolio, ranked #18.
Wimmer Associates 1 first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wimmer Associates 1 held 2,470 shares of Eli Lilly worth $2.96M as of Q2 2026.
- Wimmer Associates 1 bought 75 Eli Lilly shares in Q2 2026, an estimated $76.6K.
- Eli Lilly made up 1.34% of Wimmer Associates 1's portfolio in Q2 2026, its #18 holding.
- Wimmer Associates 1 first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wimmer Associates 1's 13F filing for Q2 2026, filed 14 Aug 2026.